Reply to letter: Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients

Affiliations

¹ Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism and Biochemistry, University of Siena, Policlinico Santa Maria alle Scotte, Viale Bracci 1, 53100 Siena, Italy.

Comment

Furio Pacini. Eur J Endocrinol. 2013.

. 2013 Oct 1;169(5):L2.

doi: 10.1530/EJE-13-0654. Print 2013 Nov.

¹ Section of Endocrinology and Metabolism, Department of Internal Medicine, Endocrinology and Metabolism and Biochemistry, University of Siena, Policlinico Santa Maria alle Scotte, Viale Bracci 1, 53100 Siena, Italy.

No abstract available

Comment on

Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients.
Castagna MG, Cevenini G, Theodoropoulou A, Maino F, Memmo S, Claudia C, Belardini V, Brianzoni E, Pacini F. Castagna MG, et al. Eur J Endocrinol. 2013 Jun 1;169(1):23-9. doi: 10.1530/EJE-12-0954. Print 2013 Jul. Eur J Endocrinol. 2013. PMID: 23594687
Post-surgical thyroid ablation in intermediate risk-differentiated thyroid cancer patients.
Rosario PW. Rosario PW. Eur J Endocrinol. 2013 Oct 1;169(5):L1. doi: 10.1530/EJE-13-0618. Print 2013 Nov. Eur J Endocrinol. 2013. PMID: 24084443 No abstract available.